Tag Archives: tracer development

Nuclear Medicine Journal
4
Feb

Overview

Nuclear Medicine Journal focuses on tracer development theranostics and quantitative PET SPECT methods; it highlights translational studies and clinical trials; articles emphasize dosimetry standardization and multicenter harmonization.

Tracer Development

Papers describe novel radiotracers for oncology neurology and cardiology; radiochemistry methods and production logistics are detailed; clinical translation challenges and regulatory pathways are discussed.

Quantification and Standards

Studies address SUV harmonization kinetic modeling and cross center calibration; guidelines for quantitative PET SPECT are proposed and validated; reproducible methods and phantom based QA are emphasized.

Theranostics and Therapy

Research on targeted radiopharmaceutical therapy and imaging biomarkers is featured; clinical outcomes safety and patient selection criteria are reported; multidisciplinary collaboration with oncology is highlighted.

Nuclear Medicine Magazine
4
Feb

Overview

Nuclear Medicine Magazine covers tracer development theranostics and quantitative imaging; it highlights clinical trials and translational research; articles support nuclear medicine physicians and technologists.

Tracer Innovation

Features describe novel PET and SPECT tracers for oncology and neurology; radiochemistry and logistics are discussed; clinical translation challenges are explored.

Theranostics

Coverage includes targeted radiopharmaceutical therapy and patient selection; safety and dosimetry considerations are presented; outcomes and case series illustrate therapeutic impact.

Quantitative Practice

Articles address SUV harmonization kinetic modeling and cross center calibration; best practices for quantitative PET are shared; readers learn methods to improve reproducibility.